Zacks Research Has Bearish Estimate for McKesson Q3 Earnings

McKesson Co. (NYSE:MCK) – Equities researchers at Zacks Research decreased their Q3 2026 earnings per share (EPS) estimates for shares of McKesson in a report released on Tuesday, February 25th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $9.56 for the quarter, down from their previous estimate of $10.02. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Zacks Research also issued estimates for McKesson’s Q2 2027 earnings at $9.03 EPS.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%.

Other research analysts have also issued research reports about the company. Bank of America reduced their target price on McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a report on Monday, January 6th. Robert W. Baird raised shares of McKesson from a “neutral” rating to an “outperform” rating and boosted their price objective for the company from $531.00 to $688.00 in a research note on Thursday, November 7th. Wells Fargo & Company increased their target price on shares of McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a research note on Friday, December 13th. Evercore ISI lifted their price objective on McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a research note on Thursday, February 6th. Finally, Mizuho initiated coverage on McKesson in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 target price on the stock. Two research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, McKesson presently has an average rating of “Moderate Buy” and an average target price of $645.79.

McKesson Price Performance

McKesson stock opened at $640.82 on Friday. McKesson has a one year low of $464.42 and a one year high of $641.70. The firm has a market capitalization of $80.31 billion, a P/E ratio of 29.34, a PEG ratio of 1.29 and a beta of 0.52. The business has a fifty day moving average price of $594.13 and a 200-day moving average price of $564.09.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be given a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date is Monday, March 3rd. McKesson’s payout ratio is presently 13.00%.

Insiders Place Their Bets

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction on Friday, February 21st. The shares were sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the completion of the sale, the chief executive officer now owns 60,664 shares of the company’s stock, valued at $36,276,465.36. This represents a 12.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Leann B. Smith sold 579 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the completion of the transaction, the executive vice president now owns 864 shares in the company, valued at $494,890.56. The trade was a 40.12 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 19,268 shares of company stock valued at $11,536,378 over the last three months. Insiders own 0.11% of the company’s stock.

Institutional Trading of McKesson

Large investors have recently modified their holdings of the business. Capital A Wealth Management LLC purchased a new position in McKesson during the 4th quarter valued at $26,000. Millstone Evans Group LLC bought a new stake in shares of McKesson during the 4th quarter valued at about $28,000. Synergy Asset Management LLC purchased a new position in shares of McKesson during the fourth quarter valued at about $32,000. MidAtlantic Capital Management Inc. bought a new position in McKesson in the third quarter worth about $29,000. Finally, Crews Bank & Trust purchased a new stake in McKesson in the fourth quarter worth about $33,000. 85.07% of the stock is owned by institutional investors.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.